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Oesphageal squamous cell
carcinoma in South Africa — an
urgent need for improved efforts
at screening and prevention
To the Editor: Oesophageal squamous cell carcinoma (OSCC) is
a major health problem among black South Africans. Recently,
Somdyala et al.1 showed that incidence rates of OSCC in certain
parts of the Transkei region remain among the highest in the
world (e.g. 76.6 and 36.5 per 10 000 respectively for males and
females from the Centane district). Clinically, OSCC is a silent
but rapidly progressive disease. Typically, patients present at
an advanced stage, and 70 - 80% of patients with malignant
dysphagia have evidence of extra-oesophageal spread,2 putting
them beyond the hope of cure. Most patients are treated by
means of oesophageal intubation, resulting in incomplete
palliation and a median survival of only 2.2 months.2 Important
therapeutic advances include improved surgical techniques,
newer chemotherapeutic agents, and the development of
coated expandable stents for treatment of oesophageal-airway
fistulas.3 However, real improvements in morbidity and
mortality rates from this deadly disease will require organised
and concerted efforts aimed at screening and prevention.
Early diagnostic testing for OSCC currently encompasses
blind oesophageal brush cytology and flexible oesophagoscopy
with iodine staining and biopsy of unstained lesions.
Experience from China indicates that population-based
screening is justified in areas endemic for OSCC.4 High-quality
clinical studies from South Africa are required to determine the
optimal screening modality, and to enable the establishment of
specific local practice guidelines for screening. A cost-efficient
infrastructure for carrying out the screening procedures (e.g. by
nurse practitioners) needs to be set in place, as well as
protocols for the handling and processing of cytological
samples. Research is urgently needed to search for better
screening modalities for OSCC, including those based on
evolving cytogenics and/or genome-wide scanning
technologies.
Prevention of OSCC requires understanding of its aetiology
and pathogenesis. Unfortunately these remain unknown, but
the geographical and racial disparities in OSCC incidence
clearly hold important clues as to possible underlying
environmental and genetic factors.5 Other potential risk factors
for South African OSCC include poor socio-economic status,
age, male sex, smoking and alcohol use (particularly in
combination), and nutritional deficiencies.6 Most exciting,
however, has been the finding of a clear epidemiological
association between the level of dietary exposure to fumonisins
and incidence of OSCC in different parts of the Transkei.7 The
fumonisins are carcinogenic mycotoxins produced by the
fungus Fusarium verticillioides (F. moniliforme), which is a natural
contaminant of maize.7 These toxins have been shown to be
hepatotoxic and hepatocarcinogenic in rats, and appear to exert
their toxic effects via oxidative damage.8 Although there is not
yet proof of cause and effect in humans, it seems prudent to
advise people from endemic OSCC areas about measures to
reduce exposure to fumonisins, e.g. improved methods for
storage of maize crops. In addition, they should be strongly
encouraged to stop smoking, to reduce alcohol intake, and to
eat a diet rich in fruit as a source of essential vitamins and
antioxidants.
Eric R Lemmer
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Cervical cancer screening
leapfrog with human papilloma-
virus testing
To the Editor: The article by Fonn in the December 2003
journal1 discusses the options and requirements for a national
cervical cancer screening programme in South Africa. It is
disappointing that she does not mention the option of using
human papillomavirus (HPV) testing instead of cytology as
there is significant evidence in the literature pointing to the
replacement of cytology with primary HPV screening.2-4 The
current problems of cytology as a screening test are a low
sensitivity of approximately 60 - 80%, many equivocal results,
and high human resource requirements as each slide has to be
read by a qualified cyto-technologist. In a resource-poor
country with high rates of cervical cancer innovative solutions
are needed.  HPV testing using molecular methods (PCR, DNA
probe) has greater sensitivity, can be automated and therefore
has greater capacity, and this may be the answer to a national
cervical cancer screening programme by leapfrogging the Pap
smear problems.  
A South African biotechnology company (Glue Health) has
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developed a self-sampling test (Sen-C-Test) for HPV testing.
The idea is to eliminate the need for speculum examination,
thereby reducing health care worker time in doing Pap smears,
to provide an automated test that has high capacity to reduce
the barriers (undergoing internal examinations) and provide
greater convenience. There has been significant independent
work done on self-sampling and HPV testing in Cape Town as
an alternative approach to screening programmes in low-
resource settings.5,6
The main disadvantage of HPV testing is specificity, and the
suggestion that we should be doing primary screening with
HPV testing followed by cytology on positive samples as
suggested by Cuzick et al.2 is highly relevant to any planned
national cervical cancer screening programme for South Africa.
Andreas Karas
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To the Editor: I wish to comment on the interesting article by
Drs Whitelaw, Currie and Littleton in a recent issue of the
Journal.1 Their article is similar to our reported cases in the
literature in which we review the historical background
published before 1965.2 
Our two cases had six sites involved.  All the lesions were
osteolytic and showed no sclerosis radiologically.2 Our patients
showed changes only in the axial skeleton — for example skull,
ribs and pelvis.  There was no evidence of pulmonary
tuberculosis radiologically.
The differential diagnosis of this condition includes
multiple myeloma and metastatic carcinoma.  These conditions
are excluded by biochemical tests, biopsy of the affected site
and the excellent response to treatment.  As tuberculosis is
readily treatable this condition, although rare, should always
be considered in the differential diagnosis of multiple osteolytic
lesions.
Y K Seedat
Nelson R Mandela School of Medicine
University of KwaZulu-Natal
Durban
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